Recipharm, a contract development and manufacturing organization (CDMO), has signed an exclusive license and collaboration agreement with Medspray and Resyca to develop soft mist nasal delivery devices for single and combination drug products.   This collaboration extends the successful partnership between Recipharm and Medspray which resulted in the joint venture, Resyca; a company which is developing soft mist inhalers utilizing Medspray’s nozzle technology to achieve high lung doses and les...